Abstract 1766: Distinct pattern of alterations in tp53 mutated and wild type acute myeloid leukemia (AML) patients
Anna Ferrari(University of Bologna), Martinelli Giovanni, Valentina Robustelli(University of Bologna), Andrea Ghelli Luserna di Rorà(Fondazione Pisa), Maria Chiara Fontana(Istituto Oncologico Romagnolo), Maria Chiara Abbenante(University of Bologna), Emanuela Ottaviani(University of Bologna), Giovanni Marconi(University of Bologna), Eugenia Franchini(University of Bologna), Elisa Zuffa(University of Bologna), Cristina Papayannidis(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Marco Manfrini(University of Padua), Giorgia Simonetti(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), Margherita Perricone(University of Bologna), Nicoletta Testoni(Thrombolysis in Myocardial Infarction Study Group), Viviana Guadagnuolo(University of Bologna), Antonella Padella(University of Bologna), Carmen Baldazzi(University of Bologna), Enrica Imbrogno(University of Bologna), Stefania Paolini(IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola), Claudia Venturi(University of Bologna), Eugenio Fonzi(University of Bologna)
Cited by 0
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
A WEE1 family business: regulation of mitosis, cancer progression, and therapeutic target
|Journal of Hematology & Oncology|2020|323
Chronic myeloid leukemia and interferon-α: a study of complete cytogenetic responders
|Blood|2001|319
The Genetic Landscape of Renal Complications in Type 1 Diabetes
|Journal of the American Society of Nephrology|2016|135